Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pembient
AddedFeb 16, 2024
UpdatedJun 18, 2026
Pembient

Pembient

Inactive

Seattle-based Pembient, a biotech firm, bioengineers wildlife products to combat global poaching.

HQ
Seattle, WA, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Pembient, a Seattle-based biotech company, was founded with the mission to combat global poaching through the creation of bioengineered wildlife products. The company's core vision is to reduce the demand for illegally poached animal parts by providing sustainable and ethical alternatives. Pembient's primary product is biofabricated horn, which is lab-made and can be customized in size for use by artisans, carvers, and designers. This innovative approach aims to replace the need for real animal horns, thus contributing to wildlife conservation efforts.

Notable individuals affiliated with Pembient include its founders and key investors who support its mission of wildlife preservation through biotechnology. The company has achieved significant milestones in developing and promoting biofabricated horn, gaining attention from conservationists and the biotech community. Pembient's impact lies in its potential to disrupt the illegal wildlife trade market by offering a viable and ethical alternative, thereby helping to protect endangered species and promote environmental sustainability.

Pembient - Similar Companies

Pneuma logo

Pneuma

pneuma.bio

Bluumbio logo

Bluumbio

bluumbio.com

BioLoom logo

BioLoom

Petri Bio logo

Petri Bio

petribio.com

Envirobe logo

Envirobe

envirobe.com

Capra Biosciences logo

Capra Biosciences

Wild Microbes logo

Wild Microbes

wildmicrobes.com

Modern Meadow logo

Modern Meadow

modernmeadow.com

Uncaged Innovations logo

Uncaged Innovations

Biomilitus logo

Biomilitus

BioHybrid Solutions logo

BioHybrid Solutions

EntoBio logo

EntoBio

Boost Biomes logo

Boost Biomes

Sci-Lume Labs logo

Sci-Lume Labs

sci-lumelabs.com

Future Fields logo

Future Fields

futurefields.io

Pembient - Quick Facts

Who are Pembient's competitors?

Companies similar to Pembient include Pneuma, Bluumbio, BioLoom and Petri Bio.

When was Pembient founded?

Pembient was founded in 2015.

Where is Pembient's headquarters located?

Pembient's headquarters is located in Seattle, WA, US.

When was Pembient's last funding round?

Pembient's most recent funding round was for $50k (USD) in January 2015.

How much has Pembient raised to-date?

As of Jan 16, 2015, Pembient has raised a total of $50k (USD).

Pembient - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Bioengineered Products
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified